Methylenetetrahydrofolate reductase and neural tube defects [5]

Lancet

Volumn 348, Issue 9019, 1996, Pages 58-

  Papapetrou, C ^a   Lynch, S A ^a   Burn, J ^a   Edwards, Y H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ENZYME VARIANT; FOLIC ACID; HOMOCYSTEINE;

AMINO ACID METABOLISM; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; HUMAN; LETTER; MALE; NEURAL TUBE DEFECT; PRIORITY JOURNAL;

EID: 0029886679     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64382-6     Document Type: Letter

References (5)

1. DL Posey Is mutated MTHFR a risk factor for neural tube defects? Lancet 347 1996 686 687
2. de Franchis R Sebastio G Mandato C Spina bifida, 677T->C mutation and role of folate Lancet 346 1995 1703
3. DEL Wilcken Wang xL Relevance to spina bifida of mutated methylenetetrahydrofolate reductase Lancet 347 1996 340
4. RS Spielman RE McGinnis WJ Ewens Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM) Am J Hum Genet 52 1993 506 516
5. MJ Khoury Case-parental control method in the search for disease- susceptibility genes Am J Hum Genet 55 1994 414 415